A Phase 1, Open-Label, Single-Dose, Non-Randomized Study to Evaluate Pharmacokinetics, Pharmacodynamics, and Safety of Betrixaban in Pediatric Patients

Trial Profile

A Phase 1, Open-Label, Single-Dose, Non-Randomized Study to Evaluate Pharmacokinetics, Pharmacodynamics, and Safety of Betrixaban in Pediatric Patients

Recruiting
Phase of Trial: Phase I

Latest Information Update: 21 Mar 2018

At a glance

  • Drugs Betrixaban (Primary)
  • Indications Venous thromboembolism
  • Focus Pharmacokinetics
  • Sponsors Portola Pharmaceuticals
  • Most Recent Events

    • 15 Mar 2018 Status changed from not yet recruiting to recruiting.
    • 15 Jan 2018 Planned initiation date changed from 1 Dec 2017 to 1 Feb 2018.
    • 20 Nov 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top